In all Australian states optometrists are permitted to use diagnostic topical ocular drugs in the practice of their profession. In addition, legislation has just been passed in Victoria allowing optometrists to prescribe topical S4 medications for ocular conditions. Changing optometric legislation to incorporate S4 ophthalmic agents is a topical issue within optometry. Methods: By postal survey, we asked Queensland optometrists to gauge their level of education, current mode of practice and whether they were in favour of gaining access to prescription-only therapeutic medications. Their opinions on the education requirements, perceived potential public benefits and the possible barriers to optometrists gaining prescribing rights to therapeutic agents were also investigated. Results: A 45 per cent response rate to the survey (231 responses out of 517) was obtained. The majority of respondents (88 per cent) wanted to be able to prescribe therapeutic agents. Over 50 per cent considered themselves competent and believed they were capable of treating dry eye, blepharitis, allergic conjunctivitis, corneal abrasions and contact lens induced papillary conjunctivitis. Over 90 per cent would be confident recommending topical lubricants and antihistamines, while 65 per cent felt they were adequately prepared to prescribe topical antibiotics. Education level, in particular the completion of a therapeutic drugs course, was the main factor that determined whether the respondents practised or were willing to practise at a higher level. Conclusion: The majority of Queensland optometrists are well aware of the issues surrounding the use of pharmaceutical agents. Many optometrists feel they are well prepared for prescribing ocular therapeutic agents. (Clin Exp Optom 2000; 83: 1: 16-31) 
Optometrists provide approximately four million patient services per year under Medicare, while ophthalmologists perform approximately 500,000 procedures per year. Patients also present to their general medical practitioner for eye-related problems. 1 Currently, in all Australian states, suitably qualified optometrists are permitted to use a range of diagnostic topical ocu-lar drugs in their role of detecting and monitoring eye disease. They may also recommend over-the-counter medications for treatment of minor ocular conditions. However, until recently, optometrists have not been permitted access to the prescription-only medications required to treat eye disease. This has had major implications for optometric practice in Aus-tralia. It is likely to most affect Australians living in rural areas which may be serviced by an optometrist but not by an ophthalmologist, and thus they will have limited access to therapeutic eye care. A similar situation exists in the United Kingdom, where optometrists are not permitted to prescribe therapeutic agents except in emergency or prophylactic situations. 2 
TPAs in optometry Schmid, Schmid, Swann and Hartley
In the United States, optometry has progressed from being a profession unable to use drugs to one where both diagnostic and therapeutic pharmaceutical agents can be used in all states. 3 Diagnostic pharmaceutical agents first became legally available to optometrists in Rhode Island in 1971. In 1976, West Virginia became the first state to allow optometrists to treat external eye disease with therapeutic agents. 4 The agents that can be used and the conditions that can be treated vary considerably from state to state. 5 The changes to drug legislation occurred progressively, with optometric patterns of practice varying depending on the state's drug laws. Wingert and Harmel 6 surveyed optometrists in three states of America, which at that time had varying laws on drug practice. They argued that eye care and access to care were enhanced in states with optometric usage of therapeutic pharmaceutical agents. However, specific changes to mode of practice occurred slowly after therapeutic drug laws were changed. 6 In Australia, Victorian optometrists gained legislative access to a complete range of topical ocular S4 pharmaceutical agents in July 1998. However, as the education requirements have just been determined, optometrists are yet to undertake the specialised training required. Similar changes are likely in New South Wales and Tasmania in the near future. Victoria was also one of the first states in Australia to gain access to ocular diagnostic agents. This occurred in 1982. Queensland optometrists did not gain access to ocular diagnostic agents until 1989 and at the time of writing this paper, a submission to the Queensland government requesting that optometrists have access to therapeutic agents had not yet been made.
Over the past decade, considerable effort has been directed by optometry's professional body, Optometrists Association Australia (OAA), and by the universitybased schools of optometry towards obtaining optometric access to therapeutic agents. Since 1991, intensive postgraduate ocular therapeutic training courses have been run throughout Australia to improve both the standard of care in optometric practice and the community's access to therapeutic eye care. In Queensland these courses commenced in 1993 and the School of Optometry, Queensland University of Technology (QUT), has been active in providing them. Similar courses have been provided in the United Kingdom. 7 The primary aim of this project was to collect current data and opinions on the issues surrounding therapeutic drug use by optometrists. These data will form an important baseline to assess changing practice modes in the future.
METHODS
In October 1998, all members of OAA (Queensland division, n = 517), except those indicated to be on leave of absence and student members, were mailed a 25-question survey on ocular therapeutic agents (Appendix 1). Participation in the survey was voluntary, optometrists were not obliged to answer all questions and all replies were strictly anonymous. The study was conducted in accordance with QUT Guidelines on Human Research Ethics.
The survey was divided into four sections: 1. demographics and access to medical practitioners 2. education 3. current mode of practice 4. future issues.
Demographics and access to medical practitioners
Questions 1 to 8 determined the optometrist's current location and access to medical services. The relationships between the optometrist and both general medical practitioners and ophthalmologists were investigated. The term comanagement has been used throughout this paper. In this context we have assumed the term to indicate that the optometrist shares the ocular care of some patients with a general medical practitioner (for example, suggesting an S4 agent for treatment of allergic conjunctivitis) or with an ophthalmologist (for example, monitoring of glaucoma progression).
Education
Questions 9 to 12 determined the optometrist's year of graduation and education level, if they are certified to use diagnostic ocular drugs, whether they have completed an ocular therapeutics drug course or have plans to undertake a course in the near future.
Current mode of practice
Questions 13 to 17 examined the techniques and ocular medications that the optometrist is comfortable with either using or recommending. Questions 16 and 17 were adapted from questions used in Doughty, Rumney and Swalwell 2 and investigated the ocular conditions that optometrists were comfortable managing and recommending medications for treatment.
Future issues
Questions 18 to 25 investigated the optometrist's opinion on future therapeutic prescribing rights for optometrists. The possible community benefits and main obstacles to optometrists prescribing S4 ocular medications were investigated. The optometrist's opinion on appropriate levels of training was also sought.
A variety of question types were used, including multiple choice, selection from a list, short answer and a combination of multiple choice with short answer. This was done in an attempt to obtain a truer representation of the optometrists' views and to give them an avenue to express their opinions and beliefs in a non-leading manner.
Data analysis
Results were collated and entered into an Excel (Microsoft 97) spreadsheet. Data were graphed using cricket graph (version 1.3.2) and analysed using the Statistical Packages for the Social Sciences (SPSS version 7.0). Unless otherwise stated, the Pearson Chi-Squared test was used to test for association, with a probability value of p = 0.05 or better used to determine significance. For statistical analysis the optometrist's year of graduation was divided into four categories: optometrists who graduated prior to 1970, in the 1970s, in the 1980s and in the 1990s. The total number of procedures that the optom-TPAs in optometry Schmid, Schmid, Swann and Hartley etrist was comfortable performing and the total number of therapeutic agents that the optometrist would be confident prescribing were determined and used for statistical analysis (Questions 14 and 15). For comparison purposes, OAA was contacted and it supplied demographic information on its membership in Queensland.
RESULTS
From the 517 surveys posted, 231 responses were received and 10 were returned to sender: a 45 per cent response rate. Not all optometrists answered all questions. If more than one answer was given to a multiple choice question, the result was not included in the analysis.
Practice demographics and access to medical services
The majority of responding optometrists (85 per cent) indicated that they worked full-time, eight per cent worked part-time, five per cent on a casual basis and one per cent of respondents were no longer practising ( Figure 1 ). This compares with OAA statistics as at July 1999 which indicate that of optometrists practising, 85 per cent work full-time, six per cent part-time, four per cent casually and five per cent were retired.
Of those responding, 55 per cent either owned their own practice or were in a partnership arrangement, 19 per cent were employees of independent optometrists, 21 per cent were employees of large optometric companies, two per cent worked as locums, two per cent were academics and one per cent worked in conjunction with ophthalmologists ( Figure 2 ). OAA statistics (July 1999) show that 45 per cent of all optometrists in Queensland own their own practice or are in a partnership arrangement, 45 per cent are salaried optometrists, seven per cent are locums and three per cent are academics.
Of the optometrists who responded to this survey, the majority (41 per cent) worked in a capital city (population greater than one million), 32 per cent worked in large towns (population over 100,000), 20 per cent worked in small towns (population greater than 10,000), The travel time from the optometry practice to the nearest general medical practitioner was minimal. A large majority of optometrists (99 per cent) indicated that a general medical practitioner was less than 10 minutes away by car, one per cent 10 minutes to one hour away, and less than one per cent indicated that more than one hour was required to reach a medical practitioner. The travel time to the nearest medical practitioner was not dependent on the location of the practice (p = 0.74); a medical practitioner was as accessible to rural optometrists as to those practising in the city.
The relationship between the optometrist and the local general medical practitioner was variable. Some optometrists (15 per cent) indicated that they frequently comanaged patients with a medical practitioner, a further 40 per cent indicated that comanagement occurred occasionally and 31 per cent indicated that comanagement did not occur. While 10 per cent of optometrists did not comment on comanagement, more than half of these individuals (56 per cent) indicated that the medical practitioner referred patients to them for visual acuity, refraction, headache investigation, glaucoma checks or visual field investigations. Five optometrists indicated that they had good personal relationships with their local medical practitioner yet no comanagement was occurring. Two optometrists explained that as they were locums, it was difficult to foster comanagement arrangements. A few optometrists (four per cent) gave no response to this question.
In some areas, ophthalmologists were not as accessible as general medical practitioners. For the majority of optometrists (72 per cent) an ophthalmologist was less than 10 minutes away by car, 22 per cent 10 minutes to one hour away, five per cent one hour to six hours away, and one per cent one day of travel away. No optometrist indicated a travel time longer than one day. There was a significant association between travel time to the nearest ophthalmologist and the optometrist's location (p = 0.001). Those in the city never reported a travel time longer than one hour; those in rural areas (54 per cent) and small towns (7.5 per cent) indicated travel times longer than one hour.
The frequency of ophthalmological visits was also related to the optometrist's location. The majority of responding optometrists (80 per cent) indicated that an ophthalmologist was available daily, 15 per cent weekly, one per cent fortnightly, three per cent monthly and one per cent quarterly. Ophthalmologists were less likely to be available in small towns and rural areas than in cities and large towns (p = 0.001). In rural areas, 44 per cent of responding optometrists, and in small towns, 10 per cent of responding optometrists, reported that an ophthalmologist was available fortnightly or less often.
The relationship that the optometrist reported that he or she had with the local ophthalmologist also varied. Thirty per cent of responding optometrists indicated that they frequently comanaged patients with the ophthalmologist, 36 per cent indicated that comanagement occurred on a limited basis, and 26 per cent indicated that comanagement did not occur. While five per cent of optometrists did not comment on comanagement, they did indicate that they performed subjective refraction or contact lens fittings for the ophthalmologist. A small number of optometrists (three per cent) gave no response to this question. Conditions under which comanagement occurred included refractive surgery, cataract surgery, glaucoma, age related maculopathy and pterygia monitoring. Five optometrists (two per cent) indicated that comanagement occurred only with ophthalmologists who were involved with laser refractive centres. A further five optometrists indicated that comanagement had occurred only with a refractive and cataract surgery centre (The Pacific Eye Centre) and that since the centre's closure they had not comanaged with ophthalmology.
Education level
Of the responding optometrists, the majority (83 per cent) graduated from the Queensland University of Technology (or Queensland Institute of Technology as it Nearly one quarter of responding optometrists (22 per cent) indicated that they had additional qualifications. These ranged from optometric qualifications, in areas such as sports vision and behavioural optometry, to degrees in other disciplines and higher degrees.
The majority of optometrists who responded (92 per cent) were registered to use diagnostic drugs. Of the 19 optometrists who were not registered, 13 indicated that they were intending to gain qualification in this area, while one was not intending to, one was unsure and four gave no response. There was a significant association with access to diagnostic drugs and year of graduation (p = 0.016) with more recent graduates being able to use diagnostic drugs. This is consistent with the fact that all graduates from 1989 to date are registered to use diagnostic drugs without further study.
Of those who were not registered to use diagnostic drugs, none had completed a therapeutic drugs course. Of those optom-etrists registered to use diagnostic drugs, 36 per cent had completed a therapeutic drugs course. The majority of these (96 per cent) had completed the course following the introduction of a Queenslandbased program in 1993. The last therapeutics drugs course at the School of Optometry, QUT, was run in 1997. The nine optometrists who graduated in 1997 and responded to the survey have not had the opportunity to undertake a course in Queensland. There was no association between year of graduation (p = 0.87), type of practice (p = 0.11) or practice location (p = 0.91) and having completed a therapeutic drugs course (Table 1) .
Of those optometrists who had not completed a therapeutic drugs course, 48 per cent indicated that they were intending to complete one and 12 per cent said they would complete a course only when legislation enabling them to prescribe therapeutic pharmaceutical agents had been passed. However, 18 per cent indicated they were not planning to undertake a course, nine per cent were unsure and 12 per cent gave no reply.
Current level of practice
The majority of responding optometrists (91 per cent) perform ophthalmoscopy through dilated pupils, though the frequency of performing a mydriatic fundus examination varied considerably. The majority (65 per cent) performed dilated pupil fundus examinations in less than 25 per cent of initial consultations, 10 per cent in 25 to 50 per cent of consultations, five per cent in 50 to 75 per cent of consultations and 11 per cent in more than 75 per cent of cases ( Figure 4 ). Optometrists who had completed a therapeutic drugs course were more likely (p = 0.001) to perform dilated pupil fundus examinations on greater numbers of patients presenting for an initial consultation than those who had not completed a therapeutic drugs course. There was no association with year of graduation (p = 0.17), type of practice (p = 0.52) or practice location (p = 0.35) and the frequency with which the pupils of patients were dilated.
There was variability in the number of techniques from the given list that the responding optometrists were comfortable performing. Over 75 per cent of responding optometrists were performing the following procedures: monitoring of glaucoma, pre-and post-cataract surgery review, binocular indirect ophthalmoscopy, ocular fundus microscopy, diagnosis of glaucoma and pre-and post-refractive surgery review. A smaller majority of optometrists (66 per cent) were comfortable with the technique of gonioscopy and 51 per cent with foreign body removal. Less than 30 per cent were confident performing lacrimal dilatation and irrigation, and punctal plug insertion. Optometrists were least familiar with scleral indentation, with only 12 per cent indicating that they were comfortable with the procedure ( Figure 5 ). The total number of procedures that the responding optometrist was comfortable performing was used for statistical analysis. There was no association between practice location (p = 0.18), type of practice (p = 0.46) or year of graduation (p = 0.08) and the total number of procedures performed. Those who were not certified to use diagnostic drugs were confident with performing fewer procedures than the optometrists who were certified (p = 0.001). Those who had completed a therapeutic drugs course were familiar with more of the listed procedures than the optometrists who had not completed a therapeutic drugs course (p = 0.002).
Responding optometrists differed in their current levels of confidence in prescribing therapeutic agents. Over 90 per cent of responding optometrists would feel comfortable recommending both topical lubricants and topical antihistamines or decongestants. A smaller number (65 per cent) would also be confident in prescribing topical antibiotics, while 25 to 35 per cent would also be prepared to prescribe topical steroids, topical NSAIDs, topical glaucoma agents and oral antihistamines or decongestants. Only 18 per cent would be willing to prescribe oral analgesics now ( Figure 6 ).
The total number of different types of therapeutic agents that the optometrist would be comfortable prescribing currently was used for statistical analysis. There was no association between practice location (p = 0.67), type of practice (p = 0.51) or year of graduation (p = 0.12) and total number of therapeutic agents that the optometrist would be prepared to recommend. Those who were not certified to use diagnostic drugs would be comfortable with prescribing fewer types of medications than those who were certified (p = 0.001). Those who had completed a therapeutic drugs course were confident in prescribing more types of medications than those optometrists who had not completed a therapeutic drugs course (p = 0.001).
Some optometrists were more comfortable with managing a wider range of conditions. In some cases, optometrists indicated that, depending on the degree of severity of the condition, they would manage the condition in different ways. For the purposes of analysis, the response most to the left in the table was taken as the optometrist's response for Question 16. Over 50 per cent of optometrists were confident managing dry eye, blepharitis, allergic conjunctivitis, corneal abrasions and contact lens induced papillary conjunctivitis (or GPC). Where comanagement with the general medical practitioner occurred, it was most commonly for the conditions of bacterial conjunctivitis, corneal foreign bodies and corneal abrasions. In situations where comanagement with an ophthalmologist occurred, it was more likely for the conditions of glaucoma and ocular hypertension, keratitis or corneal ulcer and anterior uveitis (Figure 7) .
Over 30 per cent of responding optometrists indicated that the conditions that they were not managing, but would most like to manage, were bacterial conjunctivitis, corneal foreign bodies and viral conjunctivitis, with a majority indicating that they would need some training to do so. Less than five per cent of optometrists indicated that they wanted further training to comanage any of the listed conditions TPAs in optometry Schmid, Schmid, Swann and Hartley with the general medical practitioner. To comanage with ophthalmologists, they primarily wanted training for the conditions of anterior uveitis, glaucoma and keratitis or corneal ulcer (Figure 7) .
Optometrists were most likely to recommend the use of lubricants for dry eye and topical antihistamines for allergic conjunctivitis. Many also recommended treatments for blepharitis (mainly adjunct therapy such as lid scrubs, warm compresses and the use of lid care), corneal abrasions and foreign bodies and bacterial conjunctivitis. Very few optometrists recommended specific pharmaceutical agents for treatment of keratitis or corneal ulcer, anterior uveitis, glaucoma and ocular hypertension ( Table 2 ); instead they referred these patients and left medication selection to the ophthalmologist. This is as expected, given that optometrists are not currently allowed to prescribe these agents and it would be inappropriate to suggest to ophthalmological colleagues the medications that they should prescribe.
Optometrists most commonly recommended that the general medical practitioner prescribe S4 schedule topical antibiotics for the treatment of conditions such as bacterial conjunctivitis and corneal foreign bodies and abrasions. For contact lens induced papillary conjunctivitis, they recommended the general medical practitioner use mast cell stabilisers such as Opticrom (sodium cromoglyclate) and Lomide (Iodoxamide) sor steroids such as FML (fluorometholone). They were less likely to recommend therapeutic agents to the general medical practitioner to treat the conditions of ocular hypertension and glaucoma (Table 3) .
Opinion regarding future developments
The majority of responding optometrists (88 per cent) were in favour of legislation being passed to enable optometrists to prescribe S4 ocular medications. Only 12 per cent were against legislation being changed. Sixty-seven per cent of optometrists clarified their reasons for being in favour of legislation being passed and seven per cent of optometrists indicated The reasons put forward for the optometrist being in favour of the legislation were (from most to least common): 1. Optometrists are more qualified than the general medical practitioner to diagnose and manage eye conditions. 2. There would be cost benefits in not having to send the patient to another practitioner solely for a medication prescription. 3. It is required for the primary eye care role of optometry. 4. Optometrists are well-qualified and trained to use these agents. 5. It would result in better patient care and access to treatment. 6. It would decrease waiting times for ophthalmology. 7. It would increase the professional standing of optometry in the community. 8. The public expects optometrists to be able to treat their eye conditions. The reasons put forward for the optometrist being against the legislation were (from most to least common): 1. I do not want the responsibility. 2. There will be no extra profitability. 3. I do not want the threat of malpractice claims.
I have inadequate knowledge in this area.
Optometrists who were not certified to use diagnostic drugs were less likely than those who were certified to be in favour of legislation to prescribe ocular medications (p = 0.004). Optometrists who had completed an ocular therapeutic drugs course were more likely to be in favour than optometrists who had not completed a course (95 per cent compared with 85 per cent in favour, p = 0.03). More recent graduates were more likely to be in favour than optometrists who had graduated earlier (p = 0.01). There was no association between the location of the optometrist's practice (p = 0.70), or the type of practice (p = 0.95) and the desire for medication prescribing rights.
Optometrists were aware of a wide range of benefits for the community that would occur if legislation enabling optometrists to prescribe therapeutic agents was passed. The majority (92 per cent) of responding optometrists answered this question, with many giving more than one benefit. A small number (three per cent) of optometrists indicated that there would be no benefit to the community. The main benefit for the community that optometrists could see was easier access to primary eye care with less cost (Table 4 ).
Optometrists were aware of a large range of potential obstacles to optometrists gaining prescribing rights for therapeutic agents (91 per cent of optometrists answered this question). The main obstacles put forward were: a lack of standardised education with optometrists currently having different levels of knowledge depending on the extent to which they had accessed continuing education, and possible opposition from other groups ( Table 5 ).
The majority of optometrists believed that undertaking additional course work and clinical training to prove competency in this area of optometric practice was an appropriate requirement for gaining therapeutic drug certification. Seventynine per cent of responding optometrists answered this question; 21 per cent either did not answer it or indicated that they did not wish to comment on this question. About half (51 per cent) of the optometrists responded that the current QUT-SUNY course was adequate; and 10 per cent indicated that refresher courses were required. Fifty-six per cent of optometrists indicated that clinical or hospital training was required to gain practical experience, There was no association between being certified to use diagnostic drugs (p = 0.75), having completed a therapeutic drugs course (p = 0.73), year of graduation (p = 0.25), practice location (p = 0.61), or type of practice (p = 0.47) and the perceived need for further medical training.
Numerous suggestions were made for ways that optometrists could obtain prescribing rights for ocular medications. Seventy per cent of optometrists answered this question, with 30 per cent either not answering it or indicating that they did not wish to comment on this question. The main suggestions were to liaise more closely with ophthalmology and to increase participation in continuing education ( Table 6 ).
Some optometrists felt that if changes occurred to allow optometrists to prescribe therapeutic agents, it would greatly impact on their practice, while others felt that the impact would be minimal. Seventy-six per cent of respondents answered this question. The most common change that optometrists saw was being able to prescribe therapeutic agents, while others thought they would also have to upgrade their skills and equipment (Table 7) . 
DISCUSSION
To our knowledge, this is the first study on this issue to be conducted in Australia. The findings of this paper show that there is a broad range of skill level among practising optometrists. While some optometrists appear not to have altered since graduation the way they practise, a large proportion have incorporated therapeutic agents into their patient management protocols through use of S2 agents and comanagement with general medical practitioners. This comes with the inconvenience of having to send their patients to a medical practitioner for a prescription to be written. Large numbers of practitioners have taken advantage of continuing professional education to improve their skill level beyond that which was standard at the time they graduated. Significant changes to the optometry course at QUT, such as the strengthening of bioscience and pharmacology areas, have meant that more recent graduates have more ocular therapeutic agent training than those who graduated as recently as five years ago.
Survey population
Our survey resulted in a 45 per cent response rate. It may be argued that optometrists who were interested in prescribing therapeutic agents would have been more likely to reply than those who were not interested. On the other hand, we received some very strong statements from those who did not want prescribing rights. Given this, it is more likely that those who did not respond were either: 1. Not concerned either way about whether they would be allowed to use therapeutic drugs. 2. Did not want to take the time to complete the survey. Consistent with the profile of the entire population of optometrists in Queensland, the optometrists who replied to this survey were predominantly in full-time employment. However, proportionally more optometrists who own their own practice or work in a partnership arrangement, and proportionally less who were employees, responded, compared to the total Queensland population of optom-etrists. This may indicate that those with ownership responsibilities are more concerned about the future of optometry. Similarly, proportionally more optometrists who work in large towns, and proportionally fewer who work in small towns or in rural areas, responded, compared to the total number of optometrists working in these areas.
Current level of practice
In our study, over 50 per cent of optometrists were comfortable treating the conditions of dry eye, blepharitis, allergic conjunctivitis, corneal abrasions and contact lens induced papillary conjunctivitis. This is consistent with similar findings in the United Kingdom, where over 50 per cent of optometrists were confident managing dry eye, corneal abrasions and foreign bodies. 2 In addition, in the United Kingdom over 30 per cent were also prepared to manage blepharitis, and papillary and allergic conjunctivitis. These figures had increased from those found in an earlier United Kingdom survey. 8 In a study of optometrists in Missouri, 9 following legislation to use therapeutic agents and 100 hours of continuing professional education, most optometrists (over 80 per cent) were comfortable treating corneal abrasions, conjunctivitis, blepharitis, and keratitis and performing foreign body removal.
The majority of optometrists (over 90 per cent) whom we surveyed would be confident prescribing both topical lubricants and topical antihistamines and decongestants. Sixty-five per cent also would be prepared to prescribe topical antibiotics, and 25 to 35 per cent would be comfortable prescribing topical steroids, topical NSAIDs, topical glaucoma agents and oral antihistamines and decongestants. Most optometrists in Missouri (over 85 per cent) were comfortable prescribing topical antibiotics, antihistamines and antiinflammatory agents, while slightly less than half were prepared to prescribe oral antibiotics and antihistamines. 9 Based on the already high level of current practice of many optometrists in Queensland, we would predict increases to levels similar to that shown in Missouri, soon after changes allowing the prescribing of therapeutic agents in Queensland were introduced.
Education level was the most significant factor in the number of procedures the optometrist was comfortable performing and the number of therapeutic agents the optometrist would be happy prescribing.
Optometrists who were certified to use diagnostic agents and those who had completed a therapeutic drugs course were more likely to be practising at a higher level than those who had not. Optometrists who had completed a therapeutic drugs course were also more likely to perform dilated pupil fundus examinations at an initial consultation. These results suggest that the continuing professional education courses provided do have some effect on the mode of optometric practice.
The year of graduation was not related to whether the optometrist practised at a higher level. This is consistent with studies in the United States which showed that performance in a therapeutic examination conducted in 1987 was similar for those optometrists who graduated in the period between 1960 to 1969 and those who graduated in 1980 to 1987. Optometrists who graduated in the period 1970 to 1979 performed slightly better than the other two groups. 10 This indicates that experience is important and despite many years since graduation, a high level of performance can be achieved. The individual optometrist's enthusiasm for continuing professional education and willingness to incorporate new techniques into the mode of practice were more important than the year of graduation.
Consistent with this, optometrists who were registered to use diagnostic drugs and had undertaken further study by completing a therapeutic drugs course were more likely to favour access to prescribing rights for therapeutic agents. In this case, there was an association with more recent graduates more likely to want access than earlier graduates. A large majority of responding optometrists (88 per cent) were in favour of legislation being passed to enable optometrists to prescribe S4 ocular medications. This result is comparable with a similar study in TPAs in optometry Schmid, Schmid, Swann and Hartley the United Kingdom that showed that 87.7 per cent of optometrists were in favour of the optometric use of therapeutic agents. 8
Possible community benefits
Optometrists were very aware of perceived benefits to the community of optometric access to ocular therapeutic agents. Studies in the United States have shown that there are real community benefits to be had from these changes. Optometrists are geographically more evenly distributed than ophthalmologists and therefore specialised primary eye care is much more accessible to the community. 6 The location or type of the optometrist's practice was not associated with performing more dilated pupil fundus examinations or with being more confident with more procedures or therapeutic agents. Even though there may be more benefits to rural communities than to city communities in optometrists having S4 prescribing rights, city-based optometrists were as interested as their rural colleagues in providing full scope primary eye care for their patients.
Impact on practice
The perceived impact that being able to prescribe therapeutic agents would have on the optometrist's practice was varied. Many expected little change in their situation because either they were already treating eye conditions by requesting prescriptions for their patients through a medical practitioner or because they were not intending to undertake therapeutic management. Others thought that they would have an increased demand for their services to the point where they would have to put on more staff or where it would begin to be a considerable workload for their practice. In Missouri, optometrists have been allowed to use therapeutic agents since 1986. Two years later, a survey of optometrists showed that on average the number of patients seen had increased by 12 per month. 9 A follow-up survey in 1991 revealed no difference in the number of prescriptions written, compared to the earlier study. 11 It was not until 1995 that a significant increase in the number of prescriptions written by optometrists occurred, from an average of 144 per year in 1991 to an average of 240 in 1995. During this time the number of optometrists certified to prescribe therapeutic agents rose from 50 per cent to 75 per cent of optometrists. 12 In all three of the Missouri studies, most patients were self-referred to the optometrist (90 per cent). In the United States, optometrists write only about five per cent of all prescriptions for topical ocular medications. Even in states where optometrists have had prescribing rights for a considerable time, they still do not see the majority of cases needing treatment. Nation-wide, ophthalmologists write 42 per cent of the prescriptions and 53 per cent are written by other medical practitioners. 3 Some optometrists (six per cent) felt that having access to therapeutic agents would improve their professional relationship with the ophthalmologist. This was certainly the case in Missouri, where two years after the introduction of access to therapeutic agents, 43 per cent of optometrists surveyed felt that their relationship with the ophthalmologist had improved. 9
Potential barriers
Optometrists were aware of the possible barriers to obtaining therapeutic agent prescribing rights. The key area of concern was one of education and making sure that all optometrists were educated on therapeutic drug use. In the United States, not all optometrists have prescribing rights, as some have chosen not to undertake the necessary continuing professional education. This has resulted in a two-tiered system. The profession cannot force optometrists who do not want the responsibility of therapeutic drug management to alter the way they practise. Hence, a similar two-tiered system is likely to develop in Australia.
Other potential barriers that optometrists raised were opposition from other groups, particularly medicine. This was evidenced in a 1995 questionnaire of Brisbane general medical practitioners 13 and by opposition to the legislative changes when they were proposed in Victoria. The questionnaire concerned glau-coma screening and treatment; only 41 per cent of medical practitioners thought that optometrists were the appropriate group to screen for glaucoma. Only one per cent supported a therapeutic role for optometrists. 13 In contrast, 57 per cent of general medical practitioners thought it was appropriate for the general practitioner to treat glaucoma. This is in spite of the fact that none of the respondents regularly performed tonometry and only 18 per cent performed ophthalmoscopy on a regular basis. Lack of support from medical practitioners is also an area for concern in the United Kingdom. 14 
CONCLUSIONS
This survey of the optometry profession in Queensland reveals a strong desire to increase the scope of practice of optometry to include therapeutic agents. This reflects the changes that are occurring nationally in Australia and in the United Kingdom and those that have already occurred in the United States. a. Capital city (population greater than 1 million) b. Large town (population greater than 100,000) c. Small town (population greater than 10,000) d. Rural (population less than 10,000) 4. What is the travel time by car to the nearest general medical practitioner? a. Less than 10 minutes b. 10 minutes to 1 hour c. 1 hour to 6 hours d. 1 day e. 1 to 3 days f. Greater than 3 days 5. Describe your relationship with the local general medical practitioner(s). For example: Do you comanage therapeutic patients with the GP at present? Do GPs refer to you for differential diagnosis on red eyes etc? 6. What is the travel time to the nearest ophthalmologist? a. Less than 10 minutes b. 10 
